Nek2-targeted ASO or siRNA pretreatment enhances anticancer drug sensitivity in triple‑negative breast cancer cells

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	839-847
Journal	International Journal of Oncology
State	Published - Jan 22 2013

Cite this

@article{0f91b85d3581496eb8b91dc499ff1f70,

title = "Nek2-targeted ASO or siRNA pretreatment enhances anticancer drug sensitivity in triple‑negative breast cancer cells",

author = "Jae Lee and Lauren Gollahon",

year = "2013",

month = jan,

day = "22",

language = "English",

pages = "839--847",

journal = "International Journal of Oncology",

}